Jean-Jacques Bienaim

2010

In 2010, Jean-Jacques Bienaim earned a total compensation of $5.4M as Chief Executive Officer at BioMarin Pharmaceutical, a 41% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$721,536
Option Awards$3,144,400
Salary$746,041
Stock Awards$774,360
Other$24,041
Total$5,410,378

Bienaim received $3.1M in option awards, accounting for 58% of the total pay in 2010.

Bienaim also received $721.5K in non-equity incentive plan, $746K in salary, $774.4K in stock awards and $24K in other compensation.

Rankings

In 2010, Jean-Jacques Bienaim's compensation ranked 920th out of 10,439 executives tracked by ExecPay. In other words, Bienaim earned more than 91.2% of executives.

ClassificationRankingPercentile
All
920
out of 10,439
91st
Division
Manufacturing
324
out of 3,837
92nd
Major group
Chemicals And Allied Products
74
out of 923
92nd
Industry group
Drugs
43
out of 682
94th
Industry
Pharmaceutical Preparations
36
out of 480
93rd
Source: SEC filing on March 23, 2012.

Bienaim's colleagues

We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2010.

2010

Henry Fuchs

BioMarin Pharmaceutical

Chief Medical Officer

2010

Stephen Aselage

BioMarin Pharmaceutical

Executive Vice President & Chief Business Officer

2010

Robert Baffi

BioMarin Pharmaceutical

Executive Vice President, Technical Operations

2010

Jeffrey Cooper

BioMarin Pharmaceutical

Chief Financial Officer

News

In-depth

You may also like